Lessons Learned From The Platform Era of The Obesity Market

The obesity market is undergoing a fundamental change with GLP-1 based therapies rising in popularity and eroding the stigma around pharmacotherapy. In this session we look into a future beyond GLP-1 and into consumer business models shaping this market.